Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

PFE 34.75 +0.31 (0.90%)
price chart
Pfizer Moves Up In Market Cap Rank, Passing Procter & Gamble
Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given company's stock. Many beginning ...
Morning Alert - Pfizer (PFE), General Electric (GE), Avago Technologies ...  Techsonian (press release)
Pfizer (PFE) Stock Gaining on Rare Lung Disorder Treatment Approval
"Pfizer is proud to gain approval for RAPAMUNE as the first treatment for patients with LAM, through our work with the FDA, the clinical investigation team and the LAM Foundation," said Rory O'Connor, MD, of Pfizer Inc. "This type of cooperative effort ...
Pfizer Inc. Gets FDA Green Signal For The First Drug To Treat A Rare Lung ...  Bidness ETC
Pfizer Gets OK On Drug For Rare Lung Disorder  Benzinga
Active Morning Movers: Pfizer Inc. (NYSE:PFE), Biocept, Inc. (NASDAQ:BIOC ...
On Friday, in the course of current trade, Shares of Pfizer Inc. (NYSE:PFE), gained 0.15%, and is now trading at $34.49. Pfizer, declared initial results of its global survey of more than 3,600 adults with rheumatoid arthritis (RA) in 13 countries.
Most Active Drug Manufacturing: Pfizer Inc. (NYSE:PFE), Merck & Co. Inc ...  StreetWise Report
Active Stocks in the Spotlight: Pfizer Inc. (NYSE:PFE), National Bank of ...
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); ...
Investors Selling These Stocks On Strength: QUALCOMM, Inc. (NASDAQ:QCOM ...  Wall Street Observer
Pfizer's Buy Rating Reiterated at Jefferies Group (PFE)  WKRB News
Glaxo Bulls Awaken With Calls as Pfizer Merger Chatter Escalates
“A lot of this is down to rumors about a merger with Pfizer,” said Kari Olsen, a sales trader at Tavira Monaco Sam. “There is also talk that if the CEO does go, the stock can spike up some 10 percent on the back of people thinking that the company can ...
Stocks Lure Investment- Pfizer Inc. (NYSE:PFE), ATA, Inc. (NASDAQ:ATAI ...
The French biotech company Cellectis (CLLS) is in talks regarding its possible sale by means of Pfizer Inc. (NYSE:PFE) [Trend Analysis] of the US thought to be amid the buyers, according to the Financial Times quoting people familiar with matter.
Trader's Round Up: Pfizer Inc. (NYSE:PFE), National Bank of Greece SA (NYSE ...
On Friday, Shares of Pfizer Inc. (NYSE:PFE), lost -0.23% to $34.28. For the trailing twelve months, the Return on assets value is 6.80%, ROE is 15.70%, and ROI is 8.90%.
Afternoon Movers: Pfizer Inc. (NYSE:PFE), SandRidge Energy, Inc. (NYSE:SD ...
On Wednesday, in the course of current trade, Shares of Pfizer Inc. (NYSE:PFE), gained 0.73%, and is now trading at $34.36.
Aurobindo Pharma Submits ANDA For Dolutegravir 50mg To FDA For Treatment ...  Nasdaq
Is Shire A Takeover Target For Pfizer?
Shire's already excellent product portfolio, its strong rare disease drug pipeline, and its proven ability to leverage M&A to create value makes the company an attractive investment in general, but its strong strategic fit into Pfizer's rare disease ...
2 Under-the-Radar Updates Pfizer Inc.'s Shareholders Need to Know About
Pfizer (NYSE: PFE ) is a mind-bogglingly large pharmaceutical company. As such, its quarterly updates tend to focus almost exclusively on high-profile products like the pneumococcal conjugate vaccine Prevnar 13, or clinical candidates such as its ...